Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Medicine, Cancer research, Renal cell carcinoma, Clear cell renal cell carcinoma, Gene knockdown, and Downregulation and upregulation.
Association between the recommended volume of leisure-time physical activity and erectile dysfunction: A cross-sectional analysis of the national health and nutrition examination survey, 2001–2004
Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway: Erratum
Corrigendum to “Telmisartan inhibits oxalate and calcium oxalate crystal-induced epithelial-mesenchymal transformation via PPAR-γ-AKT/STAT3/p38 MAPK-Snail pathway” [Life Sci. 241 (2020) 117108]
RAB3D, upregulated by aryl hydrocarbon receptor (AhR), promotes the progression of prostate cancer by activating the PI3K/AKT signaling pathway
Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy
FK506 binding protein 10: a key actor of collagen crosslinking in clear cell renal cell carcinoma
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum
Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma
Aryl hydrocarbon receptor enhances the expression of miR-150-5p to suppress in prostate cancer progression by regulating MAP3K12
Identification of potential key genes and high-frequency mutant genes in prostate cancer by using RNA-Seq data
Increased expression of GGN promotes tumorigenesis in bladder cancer and is correlated with poor prognosis
Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma
Retroperitoneal Laparoscopic Partial Nephrectomy for Tumors Larger than 7 cm in Renal Cell Carcinoma: Initial Experience of Single-Institution
MicroRNA-let-7f-1 is induced by lycopene and inhibits cell proliferation and triggers apoptosis in prostate cancer
USP28 is a potential prognostic marker for bladder cancer
Association of E2F3 expression with clinicopathological features of Wilms’ tumors
Genetic Polymorphisms of GSTM1, GSTT1, and GSTP1 with Prostate Cancer Risk: A Meta-Analysis of 57 Studies
Glutathione S-transferase T1 Polymorphism Contributes to Bladder Cancer Risk: A Meta-Analysis Involving 50 Studies
Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma
Expression and significance of Survivin and HLA-I in clear cell renal cell carcinoma
Journal of Modern Urology 2012cited by 0position: first
Utility of fluorescence in situ hybridization for the diagnosis of bladder urothelial carcinoma